Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells. Clinics, [S. l.], v. 67, n. 9, p. 1093–1099, 2012. DOI: 10.6061/clinics/2012(09)18. Disponível em: https://www.revistas.usp.br/clinics/article/view/45877.. Acesso em: 27 apr. 2024.